Vitrolife AB, headquartered in Sweden, is a leading player in the reproductive health industry, specialising in products and services for assisted reproductive technology (ART). Founded in 1994, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Vitrolife is renowned for its innovative solutions, including culture media, cryopreservation products, and laboratory equipment designed to enhance the success rates of IVF treatments. Their commitment to quality and research has positioned them as a trusted partner for fertility clinics worldwide. With a focus on advancing reproductive medicine, Vitrolife continues to achieve significant milestones, solidifying its reputation as a pioneer in the field.
How does Vitrolife's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vitrolife's score of 69 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Vitrolife reported total carbon emissions of approximately 19,000,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 18,725,000 kg CO2e. The breakdown of emissions includes 742,000 kg CO2e from Scope 1 and 1,200,000 kg CO2e from Scope 2 (market-based). In 2023, the company’s emissions were approximately 26,531,000 kg CO2e, with Scope 3 emissions at about 26,531,000 kg CO2e, Scope 1 at 737,000 kg CO2e, and Scope 2 at 1,180,000 kg CO2e (market-based). Vitrolife has set ambitious near-term targets through the Science Based Targets initiative (SBTi). The company aims to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2023 as the base year. Additionally, it targets a 51.6% reduction in Scope 3 emissions per million SEK value added, covering categories such as purchased goods and services, capital goods, and business travel, also by 2030. These commitments reflect Vitrolife's dedication to aligning with climate science and contributing to global efforts to limit warming to 1.5°C. The emissions data and reduction targets are sourced from Vitrolife AB (publ), ensuring transparency and accountability in their climate strategy.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 515,000 | 0,000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 702,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,199,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Vitrolife's Scope 3 emissions, which decreased by 29% last year and increased significantly since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Upstream Transportation & Distribution" being the largest emissions source at 32% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vitrolife has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Vitrolife's sustainability data and climate commitments